Multiple Assemblies exist for SMTL entry 3hkw
HCV NS5B genotype 1a in complex with 1,5 benzodiazepine inhibitor 6; X-RAY DIFFRACTION 1.55 Å

	SMTL ID 3hkw.1 Ligands (11S)-10-[(2,5-dimethyl-1,3-oxazol-4-yl)carbonyl]-11-{2-fluoro-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}-3,3-dimethyl-2,3,4,5,10,11-hexahydrothiopyrano[3,2-b][1,5]benzodiazepin-6-ol 1,1-dioxide; SULFATE ION; GLYCEROL Polypeptides NS5B RNA-dependent RNA polymerase Oligo-state monomer
	SMTL ID 3hkw.2 Ligands (11S)-10-[(2,5-dimethyl-1,3-oxazol-4-yl)carbonyl]-11-{2-fluoro-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}-3,3-dimethyl-2,3,4,5,10,11-hexahydrothiopyrano[3,2-b][1,5]benzodiazepin-6-ol 1,1-dioxide; SULFATE ION; GLYCEROL Polypeptides NS5B RNA-dependent RNA polymerase Oligo-state monomer
	SMTL ID 3hkw.3 Ligands (11S)-10-[(2,5-dimethyl-1,3-oxazol-4-yl)carbonyl]-11-{2-fluoro-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}-3,3-dimethyl-2,3,4,5,10,11-hexahydrothiopyrano[3,2-b][1,5]benzodiazepin-6-ol 1,1-dioxide; SULFATE ION Polypeptides NS5B RNA-dependent RNA polymerase Oligo-state monomer